{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:26Z","timestamp":1791198326650,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/inf.0b013e3182755a34","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T11:11:53Z","timestamp":1349349113000},"page":"39-44","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence of Lipodystrophy in HIV-infected Children in Tanzania on Highly Active Antiretroviral Therapy"],"prefix":"10.1097","volume":"32","author":[{"given":"Grace D.","family":"Kinabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirte","family":"Sprengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levina J.","family":"Msuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisa M.","family":"Shayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"van Asten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wil M.V.","family":"Dolmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.A.M.","family":"van der Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-17-20210202","first-page":"152","article-title":"Lipodystrophy and quality of life of HIV-infected persons.","volume":"10","author":"Guaraldi","year":"2008","journal-title":"AIDS Rev"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.idc.2005.05.006","article-title":"Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.","volume":"19","author":"Leonard","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","article-title":"Lipodystrophy syndrome in human immunodeficiency virus-infected children.","volume":"21","author":"Amaya","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","article-title":"Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.","volume":"12","author":"Aurpibul","year":"2007","journal-title":"Antivir Ther (Lond)"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12098-008-0037-2","article-title":"Lipodystrophy in pediatric HIV.","volume":"75","author":"Desai","year":"2008","journal-title":"Indian J Pediatr"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00431-006-0193-1","article-title":"Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.","volume":"166","author":"Ene","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.","volume":"25","author":"Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12098-009-0216-9","article-title":"Lipodystrophy and metabolic complications of highly active antiretroviral therapy.","volume":"76","author":"Parakh","year":"2009","journal-title":"Indian J Pediatr"},{"key":"R13-17-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00431-004-1610-y","article-title":"Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children.","volume":"164","author":"Sanchez Torres","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2223\/JPED.1910","article-title":"Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed.","volume":"85","author":"Sarni","year":"2009","journal-title":"J Pediatr (Rio J)"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","article-title":"Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.","volume":"114","author":"Taylor","year":"2004","journal-title":"Pediatrics"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"HIV Outpatient Study Investigators. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00126334-200308150-00004","article-title":"HIV Lipodystrophy Case Definition Study Group. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score.","volume":"33","author":"Carr","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe.","volume":"18","author":"Vigano","year":"2004","journal-title":"AIDS"},{"key":"R22-17-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","article-title":"Metabolic complications of antiretroviral therapy in children.","volume":"22","author":"Leonard","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R23-17-20210202","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1542\/peds.109.2.e25","article-title":"Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.","volume":"109","author":"Verweel","year":"2002","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201301000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T02:14:31Z","timestamp":1687745671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201301000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182755a34","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}